Amir Pansky
CEO
Claimed by owner NitiLoop
Former names:
Vascular Support Micro-catheters
NitiLoop
www.prnewswire.com
•
Apr 7, 2020
Nitiloop's NovaCross Earns FDA Clearance for Treating Chronic Total Occlusion (CTO) Prior to PTCA or Stent Intervention
www.prnewswire.com
•
Oct 26, 2017
Nitiloop Announces FDA 510(k) Clearance for its Nova Cross Extreme and Nova Cross BTK Micro catheter for Support of Guidewire Access to Discrete Regions of the Coronary and Peripheral Vasculature
www.businesswire.com
•
May 18, 2015
Nitiloop Announces FDA 510(k) Clearance for its NovaCross™ Microcatheter for Support of Guidewire Access to Discrete Regions of the Coronary and Peripheral Vasculature
About
Nitiloop has developed the NovaCross, a microcatheter that enables guidewire positioning and distal support, with an extendable segment for additional support. The NovaCross, comprising a competent supporting microcatheter and a low-profile microcatheter, uses an operator-controlled nitinol scaffold and an extendable segment, both at its distal tip.
The proprietary platform used in the NovaCross is also used as a basis for additional products intended for below-the-knee and embolotherapy applications, the treatment of liver cancer with chemotherapy, and the injection of radiation beads through the microcatheter.
The proprietary platform used in the NovaCross is also used as a basis for additional products intended for below-the-knee and embolotherapy applications, the treatment of liver cancer with chemotherapy, and the injection of radiation beads through the microcatheter.
Employees
Product stage
Primary Sector
Life Sciences & HealthTech
Products
NovaCross
Geographic markets
-
Funding
Total Funding
Undisclosed
Last Funding
Undisclosed
Funding Stage
Total Rounds
1
Investors
1
News
(3)
www.prnewswire.com
•
Apr 7, 2020
Nitiloop's NovaCross Earns FDA Clearance for Treating Chronic Total Occlusion (CTO) Prior to PTCA or Stent Intervention
www.prnewswire.com
•
Oct 26, 2017
Nitiloop Announces FDA 510(k) Clearance for its Nova Cross Extreme and Nova Cross BTK Micro catheter for Support of Guidewire Access to Discrete Regions of the Coronary and Peripheral Vasculature
www.businesswire.com
•
May 18, 2015
Nitiloop Announces FDA 510(k) Clearance for its NovaCross™ Microcatheter for Support of Guidewire Access to Discrete Regions of the Coronary and Peripheral Vasculature
The Team
(3)
AP
RK
Ran Kornowski
CMO
IH
Itamar Haran
Operations Leader
Connect with
What is the reason for connecting?
Your company *
Your position *
Add invitation message
0/300
Sending invitation...
Company Lifecycle
Private Equity Funding
Undisclosed Round
Undisclosed
May 2015
1 Investors
Undisclosed
Others
Academic Techonology
Jan 2011
undefined
Vascular Support Micro-catheters
Media gallery
(1)
The Nova Cross
Locations
Israel
Tidhar St 1, Pardes Hanna-Karkur, Israel
Locations
Israel
Tidhar St 1, Pardes Hanna-Karkur, Israel
Unlock financial data
Finder is provided for free by the non-profit organization Start-Up Nation Central.
- Get unlimited search results
- Save to custom lists - Smartlists
- Get notified with news and updates
- Connect with people
And much more...
I already have access,